e-learning
resources
Paris 2018
Sunday, 16.09.2018
Occupational and environmental lung diseases: asthma and the airways
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Profiling of hypersensitivity pneumonitis diagnosed at a UK specialist service for ILD and occupational lung diseases
G. Walters (Birmingham, United Kingdom), J. Mokhlis (Birmingham, United Kingdom), V. Moore (Birmingham, United Kingdom), G. Burge (Birmingham, United Kingdom), A. Robertson (Birmingham, United Kingdom), S. Burge (Birmingham, United Kingdom)
Source:
International Congress 2018 – Occupational and environmental lung diseases: asthma and the airways
Session:
Occupational and environmental lung diseases: asthma and the airways
Session type:
Poster Discussion
Number:
372
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Walters (Birmingham, United Kingdom), J. Mokhlis (Birmingham, United Kingdom), V. Moore (Birmingham, United Kingdom), G. Burge (Birmingham, United Kingdom), A. Robertson (Birmingham, United Kingdom), S. Burge (Birmingham, United Kingdom). Profiling of hypersensitivity pneumonitis diagnosed at a UK specialist service for ILD and occupational lung diseases. 372
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
How consistently do physicians diagnose and manage drug-induced interstitial lung disease? Two surveys of European ILD specialist physicians
Source: ERJ Open Res, 6 (1) 00286-2019; 10.1183/23120541.00286-2019
Year: 2020
Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan
Source: ERJ Open Res, 6 (2) 00184-2019; 10.1183/23120541.00184-2019
Year: 2020
Ocular manifestations in unselected group of sarcoid patients hospitalised in the national tuberculosis and lung diseases research institute
Source: Eur Respir J 2002; 20: Suppl. 38, 435s
Year: 2002
Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006
Approaches to the diagnosis of asbestos-related lung disease amongst UK respiratory physicians-BTS survey
Source: Eur Respir J 2006; 28: Suppl. 50, 692s
Year: 2006
Environmental exposures in 513 patients of hypersensitivity pneumonitis: Prospective ILD India registry
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Impact of a specialist respiratory pharmacist in the management of interstitial lung disease
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018
Pattern and impact of rheumatology referral in patients with ILD and autoimmune features
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
The value of a specialist nurse-lead interstitial lung disease clinic, patients’ views
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015
Clinical highlights from the 2011 ERS Congress in Amsterdam
Source: Eur Respir J 2012; 39: 1501-1510
Year: 2012
Comparison of registries of interstitial lung diseases in three European countries
Source: Eur Respir J 2001; 18: 114S-118S
Year: 2001
Differing clinical courses of IPF at an acute district general hospital
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Employment, treatment and lung function outcomes at 1-year following diagnosis of occupational hypersensitivity pneumonitis
Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease
Year: 2020
Myositis-associated interstitial pneumonia (MaIP): Autoantibody associations in patients presenting to pulmonologists and rheumatologists
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
Perception of primary care physicians on chronic obstructive pulmonary disease and asthma: a study in India
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017
Determinants of vaccination in patients with community acquired pneumonia (CAP) or chronic lung diseases
Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence
Year: 2004
Acute exacerbations of interstitial lung diseases:experience of 6 years from a portuguese hospital center
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2
Year: 2020
Progressive fibrosing interstitial lung diseases (PF-ILDs): prevalence and characterization in two Italian referral centers
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Delivery of asthma and chronic obstructive pulmonary disease (COPD) services in UK primary care: nurses‘ roles and responsibilities
Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept